- Home
- DRUG vs HLXB Comparison
DRUG vs HLXB Comparison
Compare DRUG & HLXB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRUG
- HLXB
- Stock Information
- Founded
- DRUG 2019
- HLXB 2021
- Country
- DRUG United States
- HLXB United States
- Employees
- DRUG N/A
- HLXB N/A
- Industry
- DRUG Pharmaceuticals and Biotechnology
- HLXB
- Sector
- DRUG Health Care
- HLXB
- Exchange
- DRUG Nasdaq
- HLXB NYSE
- Market Cap
- DRUG 260.6M
- HLXB 250.4M
- IPO Year
- DRUG N/A
- HLXB 2024
- Fundamental
- Price
- DRUG $37.65
- HLXB $10.70
- Analyst Decision
- DRUG Strong Buy
- HLXB
- Analyst Count
- DRUG 4
- HLXB 0
- Target Price
- DRUG $84.33
- HLXB N/A
- AVG Volume (30 Days)
- DRUG 91.2K
- HLXB 6.9K
- Earning Date
- DRUG 12-31-2024
- HLXB 01-01-0001
- Dividend Yield
- DRUG N/A
- HLXB N/A
- EPS Growth
- DRUG N/A
- HLXB N/A
- EPS
- DRUG N/A
- HLXB N/A
- Revenue
- DRUG N/A
- HLXB N/A
- Revenue This Year
- DRUG N/A
- HLXB N/A
- Revenue Next Year
- DRUG N/A
- HLXB N/A
- P/E Ratio
- DRUG N/A
- HLXB N/A
- Revenue Growth
- DRUG N/A
- HLXB N/A
- 52 Week Low
- DRUG $0.93
- HLXB $10.03
- 52 Week High
- DRUG $79.02
- HLXB $11.59
- Technical
- Relative Strength Index (RSI)
- DRUG 55.50
- HLXB N/A
- Support Level
- DRUG $28.21
- HLXB N/A
- Resistance Level
- DRUG $38.00
- HLXB N/A
- Average True Range (ATR)
- DRUG 2.86
- HLXB 0.00
- MACD
- DRUG 0.45
- HLXB 0.00
- Stochastic Oscillator
- DRUG 96.42
- HLXB 0.00
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
About HLXB HELIX ACQUISITION CORP. II
Helix Acquisition Corp II is a Blank check company.